MXCT vs PPL · rev $38.6M vs P/E 22, rev $8.46B
MaxCyte Inc (MXCT) versus PPL Corporation (PPL) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported PPL revenue for 2024-12-31 was $8.46B. Net income was $888.0M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
MXCT currently screens at market cap $124.3M. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Not investment advice. Open the MXCT and PPL stock pages for the full models.
Not investment advice.